Faron Pharmaceuticals

Overview

• HeadquartersTurku, Finland¹
• Legal formosakeyhtiö¹
• LEI7437009H31TO1DC0EB42³
• StatusActive³
• LEI statusIssued and current³
• Registered addressJoukahaisenkatu 6, FI-20520 Turku, Finland³
• Registered withFinnish Patent and Registration Office, 2068285-4³

See how the biggest companies compare on our leaderboards

Faron Pharmaceuticals is a Finnish drug discovery and development company based in Turku, Finland. The company was founded in 2003 by a group led by Markku Jalkanen, who now acts as the company's Chief Executive Officer.²

The story

Founded by Markku Jalkanen.¹

Leadership

Who has led Faron Pharmaceuticals, and when. Pick a name to see everywhere that person has worked.

• FounderMarkku Jalkanen¹

Timeline

1. Oct 18, 2006Founded Faron Pharmaceuticals is founded³

Calendar

Drug trials and FDA: coming up

1. Mar 2027Phase 1/2 trial readout expected Phase 1/2 trial of Bexmarilimab, Azacitidine and others in Acute Myeloid Leukemia: primary completion expected Mar 2027 (ClinicalTrials.gov NCT05428969).⁴

Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). Trials from ClinicalTrials.gov, as the sponsor registered them (expected dates are the sponsor's own and often move); approvals and advisory committee meetings from the FDA. The FDA does not publish its decision (PDUFA) dates. The full markets calendar

Links

• WikipediaFaron Pharmaceuticals
• WikidataQ56401074